BIOLASE Revenue and Competitors
Estimated Revenue & Valuation
- BIOLASE's estimated annual revenue is currently $35M per year.
- BIOLASE's estimated revenue per employee is $83,333
- BIOLASE's total funding is $91.4M.
Employee Data
- BIOLASE has 420 Employees.
- BIOLASE grew their employee count by -1% last year.
BIOLASE's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Regulatory Affairs & Quality Assurance | Reveal Email/Phone |
2 | VP, Human Resources | Reveal Email/Phone |
3 | VP, Clinical Strategic Alliances | Reveal Email/Phone |
4 | VP, Operations | Reveal Email/Phone |
5 | VP Innovation and Business Development | Reveal Email/Phone |
6 | VP Regulatory Affairs & Quality Assurance | Reveal Email/Phone |
7 | Senior Director, Dental Education & Professional Relations | Reveal Email/Phone |
8 | Director Engineering | Reveal Email/Phone |
9 | Chief Operating Officer | Reveal Email/Phone |
10 | Director Continuous Improvement | Reveal Email/Phone |
BIOLASE Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $58M | 231 | -1% | N/A | N/A |
What Is BIOLASE?
BioLase Technology Inc. is a medical technology company operating in one business segment that designs, manufactures and markets advanced dental, cosmetic and surgical laser and related products. The Company\'s primary product, the Waterlase system, precisely cuts hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue and dental structure. Its LaserSmile system is designed to complement the Waterlase, and is used in soft tissue procedures and tooth whitening. BioLase has clearance from the United States Food and Drug Administration (FDA) to market its laser systems in the United States. It also has the approvals necessary to sell its laser systems in Canada, the European Union and other international markets.
keywords:N/A$91.4M
Total Funding
420
Number of Employees
$35M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BIOLASE News
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products...
Colliers Securities restated a buy rating on shares of BIOLASE in a research report on Tuesday, March 22nd. Zacks Investment Research upgraded...
Get BIOLASE alerts: This table compares BIOLASE and ZimVie's gross revenue, earnings per share and valuation.
FOOTHILL RANCH, Calif., Sept. 14, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and Healthy Smiles for Kids of Orange County (Healthy Smiles) are inviting dental professionals in the Orange County area to an awareness reception around the shared mission ...
FOOTHILL RANCH, Calif., Aug. 31, 2021 /PRNewswire/ -- Today BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan that will help expand laser adoption and increase hands-on training programs with one of the glob ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $111.6M | 425 | 7% | N/A |
#2 | $143.4M | 425 | -9% | N/A |
#3 | $136M | 427 | -9% | $154.4M |
#4 | $79.4M | 431 | -15% | $163.2M |
#5 | $146.5M | 434 | 2% | N/A |